C6 NBD Galactosylceramide [170212-26-7]

Referência NB-64-88386-25mg

Tamanho : 25mg

Marca : Neo Biotech

Contactar o distribuidor local :


Telefone : +1 850 650 7790

Remove All

C6 NBD Galactosylceramide

(Synonyms: N-hexanoyl-NBD-Galactosylceramide, NBD GalCer(d18:1/6:0), NBD Galactosylceramide (d18:1/6:0), C6-NBD-GalCer) Copy Product Info

Synonyms: N-hexanoyl-NBD-Galactosylceramide, NBD GalCer(d18:1/6:0), NBD Galactosylceramide (d18:1/6:0), C6-NBD-GalCer

Catalog No. T85989 Copy Product Info
C6 NBD galactosylceramide, an active derivative of galactosylceramide tagged with fluorescent nitrobenzoxadiazole (NBD), serves as a substrate for neutral β-glycosylceramidase (GCase) in studies of intracellular localization and metabolism of galactosylceramide (Ex=nm, Em=525) [1].
Cas No. 170212-26-7
For research use only—not for human use. No sales to individuals. Use as intended only.

Product Introduction

Bioactivity
Description
C6 NBD galactosylceramide, an active derivative of galactosylceramide tagged with fluorescent nitrobenzoxadiazole (NBD), serves as a substrate for neutral β-glycosylceramidase (GCase) in studies of intracellular localization and metabolism of galactosylceramide (Ex=nm, Em=525) [1].
In vitro
C6-NBD-glucosylceramide (4 μM) undergoes transport to the Golgi apparatus in HT29 cells [1]. According to our recommended protocol, transcytosis of exogenous C6-NBD-GaICer follows these steps after endocytosis: Initially, C6-NBD-glucosylceramide is inserted at 10°C. Subsequently, cells are subjected to three cold HBSS rinses and maintained at 37°C in HBSS to facilitate endocytosis. After 10 minutes, residual probe on the cell surface is eliminated through either two (apical) or three (basal) 20-minute BSA washes at 10°C. Lipid analysis using one set of filters quantifies the endocytosis, while a second set incubated for either 0.5 or 1 hour at 37°C in HBSS + BSA measures the reemergence of intracellular C6-NBD-glucosylceramide on the cell surfaces. Post-incubation, a 10°C BSA wash is conducted before extracting the NBD lipids into chloroform/methanol from both apical and basal media, as well as the cells, which are then analyzed and quantitated by TLC.

The above information is based on published literature. Experimental procedures should be appropriately modified to meet specific research demands.
SynonymsN-hexanoyl-NBD-Galactosylceramide, NBD GalCer(d18:1/6:0), NBD Galactosylceramide (d18:1/6:0), C6-NBD-GalCer
Chemical Properties
Molecular Weight737.88
FormulaC36H59N5O11
Cas No.170212-26-7
SmilesN(CCCCCC(N[C@@H](CO[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O)[C@@H](/C=C/CCCCCCCCCCCCC)O)=O)C=2C=3C(C(N(=O)=O)=CC2)=NON3
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature.

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 µL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 µL Tween 80 and mix well until fully clarified.

3) Add 450 µL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.

Dose Conversion

Related Tags: C6 NBD Galactosylceramide chemical structure | C6 NBD Galactosylceramide in vitro | C6 NBD Galactosylceramide formula | C6 NBD Galactosylceramide molecular weight